These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15648190)

  • 21. Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection.
    Asahi-Ozaki Y; Itamura S; Ichinohe T; Strong P; Tamura S; Takahashi H; Sawa H; Moriyama M; Tashiro M; Sata T; Kurata T; Hasegawa H
    Microbes Infect; 2006 Oct; 8(12-13):2706-14. PubMed ID: 16968669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination.
    Hirabayashi Y; Kurata H; Funato H; Nagamine T; Aizawa C; Tamura S; Shimada K; Kurata T
    Vaccine; 1990 Jun; 8(3):243-8. PubMed ID: 2363302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholera toxin conjugates for intragastric vaccination against herpes simplex virus type 2.
    Drew MD; Estrada AE; Underdown BJ; McDermott MR
    Reg Immunol; 1992; 4(2):79-85. PubMed ID: 1503890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probing the protective effects of a conformationally constrained nicotine vaccine.
    Moreno AY; Azar MR; Koob GF; Janda KD
    Vaccine; 2012 Oct; 30(47):6665-70. PubMed ID: 22963803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
    Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
    Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
    Isaka M; Yasuda Y; Kozuka S; Miura Y; Taniguchi T; Matano K; Goto N; Tochikubo K
    Vaccine; 1998 Oct; 16(17):1620-6. PubMed ID: 9713937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-nicotine abuse vaccines in the pipeline: an update.
    Cerny EH; Cerny T
    Expert Opin Investig Drugs; 2008 May; 17(5):691-6. PubMed ID: 18447595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of vaccination with recombinant HpaA from Helicobacter pylori is influenced by host genetic background.
    Sutton P; Doidge C; Pinczower G; Wilson J; Harbour S; Swierczak A; Lee A
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):213-9. PubMed ID: 17567282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain.
    Hieda Y; Keyler DE; Ennifar S; Fattom A; Pentel PR
    Int J Immunopharmacol; 2000 Oct; 22(10):809-19. PubMed ID: 10963853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of systemic antifimbria and antitoxin antibody responses in Egyptian children and adults by an oral, killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine.
    Hall ER; Wierzba TF; Ahrén C; Rao MR; Bassily S; Francis W; Girgis FY; Safwat M; Lee YJ; Svennerholm AM; Clemens JD; Savarino SJ
    Infect Immun; 2001 May; 69(5):2853-7. PubMed ID: 11292698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recent progress in vaccines against nicotine addiction].
    Wang GB; Zhu CJ
    Yao Xue Xue Bao; 2013 Aug; 48(8):1189-94. PubMed ID: 24187824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge.
    Glenn GM; Scharton-Kersten T; Vassell R; Mallett CP; Hale TL; Alving CR
    J Immunol; 1998 Oct; 161(7):3211-4. PubMed ID: 9759833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.
    Yasuda Y; Isaka M; Taniguchi T; Zhao Y; Matano K; Matsui H; Morokuma K; Maeyama J; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Jun; 21(21-22):2954-63. PubMed ID: 12798639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid.
    Isaka M; Yasuda Y; Kozuka S; Taniguchi T; Miura Y; Matano K; Goto N; Tochikubo K
    Vaccine; 1999 Feb; 17(7-8):944-8. PubMed ID: 10067701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit.
    Oien NL; Brideau RJ; Walsh EE; Wathen MW
    Vaccine; 1994 Jun; 12(8):731-5. PubMed ID: 8091852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal vaccination approach against mosquito-borne Japanese encephalitis virus.
    Harakuni T; Kohama H; Tadano M; Uechi G; Tsuji N; Matsumoto Y; Miyata T; Tsuboi T; Oku H; Arakawa T
    Jpn J Infect Dis; 2009 Jan; 62(1):37-45. PubMed ID: 19168957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment and prevention of tobacco addiction. Antinicotinic vaccine].
    Fernández PL
    An R Acad Nac Med (Madr); 2012; 129(1):295-304; discussion 304-6. PubMed ID: 24294730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negatively Charged Carbon Nanohorn Supported Cationic Liposome Nanoparticles: A Novel Delivery Vehicle for Anti-Nicotine Vaccine.
    Zheng H; Hu Y; Huang W; de Villiers S; Pentel P; Zhang J; Dorn H; Ehrich M; Zhang C
    J Biomed Nanotechnol; 2015 Dec; 11(12):2197-210. PubMed ID: 26510313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular attributes of conjugate antigen influence function of antibodies induced by anti-nicotine vaccine in mice and non-human primates.
    McCluskie MJ; Thorn J; Mehelic PR; Kolhe P; Bhattacharya K; Finneman JI; Stead DR; Piatchek MB; Zhang N; Chikh G; Cartier J; Evans DM; Merson JR; Davis HL
    Int Immunopharmacol; 2015 Apr; 25(2):518-27. PubMed ID: 25737198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune responses to the oral administration of recombinant Bacillus subtilis expressing multi-epitopes of foot-and-mouth disease virus and a cholera toxin B subunit.
    Hu B; Li C; Lu H; Zhu Z; Du S; Ye M; Tan L; Ren D; Han J; Kan S; Wang J; Jin N
    J Virol Methods; 2011 Jan; 171(1):272-9. PubMed ID: 21129406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.